Latest News and Press Releases
Want to stay updated on the latest news?
-
BioVersys Announces First Patient First Visit in HABP/VABP Pivotal Phase 3 RIV-TARGET Trial of BV100
BASEL, Switzerland, April 16, 2026 (GLOBE NEWSWIRE) -- BV100 is a potential best-in-class anti-infective agent in treating hospital-acquired bacterial pneumonia (HABP) or ventilator-associated...
-
Washington, DC, April 15, 2026 (GLOBE NEWSWIRE) -- The Association for Frontotemporal Degeneration (AFTD) hosted its first Capitol Hill briefing, Frontotemporal Degeneration: Shining a Light on a...
-
Elion Therapeutics initiated a Phase 2 study of turletricin in invasive mould infection ("TREAT-1") and is presenting early clinical data at ESCMID 2026.
-
Washington, DC, April 15, 2026 (GLOBE NEWSWIRE) -- The Association for Frontotemporal Degeneration (AFTD) hosted its first Capitol Hill briefing, Frontotemporal Degeneration: Shining a Light on a...
-
Riyadh, Saudi Arabia, April 15, 2026 (GLOBE NEWSWIRE) -- On the evening of April 15, HRH Prince Turki Alfaisal, Acting Chairman of the Board of Trustees of King Faisal Foundation, and King Faisal...
-
Shingles isn’t just a painful rash and nerve pain. It’s also linked with a higher risk of serious cardiovascular events, including heart attack and stroke.
-
FORT WALTON BEACH, Fla., April 15, 2026 (GLOBE NEWSWIRE) -- Aurisha Smolarski, licensed marriage and family therapist (LMFT), certified co-parenting coach, mediator, and author, is joining leading...
-
Researchers at IOB developed targeted delivery of healthy mitochondria to diseased cells, opening new paths for treating mitochondrial disorders.
-
PHILADELPHIA, April 15, 2026 (GLOBE NEWSWIRE) -- Cerene®, developed by Channel Medsystems, a leader in innovative women’s health solutions, is proud to announce its partnership with Hey Girl! Fund...
-
MENLO PARK, Calif. and WOBURN, Mass., April 15, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, and Covaris, a PerkinElmer...